Related Experiment Video
Updated: Jun 30, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
The Canadian Women's Heart Health Alliance ATLAS on the Epidemiology, Diagnosis, and Management of Cardiovascular
Marie-Annick Clavel1, Harriette G C Van Spall2, Laura E Mantella3
1Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, Québec, Canada.
Knowledge gaps persist in women's heart health, impacting diagnosis and treatment. Addressing these requires improved research, education, and policy for better cardiovascular care in women.
Area of Science:
- Cardiovascular Medicine
- Women's Health
- Medical Research
Background:
- Heart disease is the leading cause of death for women globally.
- Historically, research has overlooked sex and gender differences in cardiovascular disease.
- Limited understanding of unique risks and symptoms in women contributes to knowledge gaps.
Purpose of the Study:
- To review the current state of cardiovascular research in Canada focusing on women.
- To highlight persistent knowledge gaps in women's heart health across various domains.
- To emphasize the need for sex- and gender-specific approaches in cardiovascular research and practice.
Main Methods:
- Review of existing cardiovascular research in Canada.
- Analysis of literature concerning epidemiology, presentation, management, and outcomes of heart disease in women.
- Identification of gaps in preclinical, clinical research, and data analysis regarding sex and gender.
Main Results:
- Significant knowledge gaps identified in women's heart health research and publications.
- Historical exclusion of female participants and sex/gender analysis in cardiovascular studies.
- Suboptimal treatment and understanding of heart disease mechanisms in women due to data limitations.
Conclusions:
- Addressing knowledge gaps in women's heart health is critical for improving cardiovascular outcomes.
- A multipronged approach involving education, policy change, and evidence-based research is necessary.
- Enhanced awareness and training for healthcare providers are essential for accurate diagnosis and treatment of heart disease in women.
More Related Videos
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
06:43Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
Published on: December 7, 2013
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Pulse amplitude and quality
A weak or absent pulse may indicate reduced cardiac output or poor left ventricular contraction, which can be signs of cardiovascular dysfunction or...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure Drugs: β-Blockers